isomethyleugenol has been researched along with Leukemia, Myelomonocytic, Juvenile in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, YL; Zhang, JL; Zhu, XF | 1 |
| Adjaoud, D; Ahmadian, MR; Baruchel, A; Bertrand, Y; Cassinat, B; Cavé, H; Caye, A; Chomienne, C; Contet, A; Dalle, JH; Dvorsky, R; Fenneteau, O; Galambrun, C; Gazal, S; Guidez, F; Häussinger, D; Lachenaud, J; Lainey, E; Méchinaud, F; Nakhaei-Rad, S; Nelken, B; Nouri, K; Paillard, C; Pereira, S; Petit, A; Picard, C; Poirée, M; Reguerre, Y; Sirvent, N; Strullu, M; Verger, E; Vidaud, D; Vivent, J | 1 |
1 review(s) available for isomethyleugenol and Leukemia, Myelomonocytic, Juvenile
| Article | Year |
|---|---|
[Advances in the treatment of juvenile myelomonocytic leukemia].
Topics: Child; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelomonocytic, Juvenile; Methylation; Myelodysplastic Syndromes; Signal Transduction | 2018 |
1 other study(ies) available for isomethyleugenol and Leukemia, Myelomonocytic, Juvenile
| Article | Year |
|---|---|
Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network.
Topics: Acetylation; Acute Disease; Child; Child, Preschool; Disease Progression; DNA Copy Number Variations; Female; Gene Regulatory Networks; Histones; Humans; Infant; Leukemia, Myeloid; Leukemia, Myelomonocytic, Juvenile; Male; Methylation; Microscopy, Confocal; Mutation; Phosphatidylinositol 3-Kinases; Polycomb Repressive Complex 2; Protein Subunits; ras Proteins; Sequence Analysis, DNA; Signal Transduction; Survival Analysis; Transcriptome | 2015 |